Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 2,029 Shares

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,029 shares of the stock in a transaction on Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $46,382.94. Following the completion of the transaction, the chief operating officer now directly owns 754,903 shares of the company’s stock, valued at $17,257,082.58. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Monday, April 8th, Evan Roberts sold 7,178 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $162,366.36.
• On Thursday, March 21st, Evan Roberts sold 25,962 shares of Phreesia stock. The shares were sold at an average price of $23.52, for a total value of $610,626.24.

Phreesia Trading Up 0.7 %

PHR traded up $0.16 on Wednesday, hitting $23.16. The company had a trading volume of 383,738 shares, compared to its average volume of 522,719. The firm has a market cap of $1.31 billion, a P/E ratio of -9.19 and a beta of 0.92. Phreesia, Inc. has a 1 year low of $12.05 and a 1 year high of $34.98. The company’s fifty day moving average price is $24.56 and its 200 day moving average price is $21.23. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.58) by $0.02. The firm had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. Phreesia’s revenue was up 24.0% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.72) EPS. As a group, equities analysts expect that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Hedge Funds Weigh In On Phreesia

Several institutional investors have recently bought and sold shares of PHR. International Assets Investment Management LLC grew its position in Phreesia by 1,987.3% in the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after acquiring an additional 1,411 shares in the last quarter. Captrust Financial Advisors grew its position in Phreesia by 154.6% in the 2nd quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after acquiring an additional 866 shares in the last quarter. Acadian Asset Management LLC acquired a new position in Phreesia in the 1st quarter valued at about $43,000. State of Wyoming grew its position in Phreesia by 34.6% in the 2nd quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after acquiring an additional 493 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its position in Phreesia by 85.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after acquiring an additional 1,445 shares in the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. DA Davidson reissued a “neutral” rating and issued a $32.00 price objective on shares of Phreesia in a research note on Friday, March 15th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Friday, March 15th. Canaccord Genuity Group lifted their price target on Phreesia from $36.00 to $37.00 and gave the stock a “buy” rating in a report on Friday, March 15th. Truist Financial started coverage on Phreesia in a report on Monday, February 26th. They set a “buy” rating and a $35.00 price target on the stock. Finally, Robert W. Baird lifted their price target on Phreesia from $30.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, March 18th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, Phreesia has an average rating of “Moderate Buy” and an average price target of $31.62.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.